# Rosalind Advisors, Inc.: Form 13F holdings

An institutional investment manager in TORONTO. SEC CIK 1622627.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $269.2m
- Positions: 35 (35 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1622627/000162262726000022/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [DELCATH SYSTEMS, INC. (DCTH)](/companies/dcth.md) | COM NEW | $41.6m | 15.4% | 3,300,389 |  | Unchanged |
| [FENNEC PHARMACEUTICALS INC (FENC)](/companies/fenc.md) | COM | $34.3m | 12.7% | 3,188,001 |  | Added +279,800 |
| [XERIS BIOPHARMA HOLDINGS INC (XERS)](/companies/xers.md) | COM | $23.0m | 8.6% | 2,908,981 |  | Reduced −322,719 |
| [SAVARA INC (SVRA)](/companies/svra.md) | COM | $19.6m | 7.3% | 3,178,121 |  | Reduced −25,600 |
| [VERASTEM INC (VSTM)](/companies/vstm.md) | COM NEW | $15.2m | 5.7% | 3,986,509 |  | Added +1,848,034 |
| [X4 PHARMACEUTICALS INC (XFOR)](/companies/xfor.md) | COM NEW | $15.0m | 5.6% | 3,214,766 |  | Unchanged |
| [EYEPOINT PHARMACEUTICALS INC (EYPT)](/companies/eypt.md) | COM NEW | $14.1m | 5.2% | 988,230 |  | Reduced −48,507 |
| CYBIN INC | COM NEW | $12.9m | 4.8% | 1,956,814 |  | Added +425,000 |
| [VOR BIOPHARMA INC (VOR)](/companies/vor.md) | COM NEW | $11.9m | 4.4% | 648,600 |  | Reduced −51,400 |
| [VAXCYTE INC (PCVX)](/companies/pcvx.md) | COM | $11.6m | 4.3% | 200,000 |  | Reduced −90,000 |
| MEDIWOUND LTD | SHS NEW | $11.0m | 4.1% | 749,054 |  | Unchanged |
| [CELLDEX THERAPEUTICS INC (CLDX)](/companies/cldx.md) | COM NEW | $7.4m | 2.8% | 200,000 |  | Reduced −130,000 |
| [BIOCRYST PHARMACEUTICALS INC (BCRX)](/companies/bcrx.md) | COM | $7.2m | 2.7% | 721,504 |  | Reduced −201,553 |
| [PROFOUND MEDICAL CORP (PROF)](/companies/prof.md) | COM NEW | $5.5m | 2.0% | 828,118 |  | Unchanged |
| [TALPHERA INC (TLPH)](/companies/tlph.md) | COM NEW | $5.3m | 2.0% | 5,169,501 |  | Added +1,815,585 |
| [ATEA PHARMACEUTICALS INC (AVIR)](/companies/avir.md) | COM | $5.0m | 1.8% | 1,070,550 |  | Reduced −101,305 |
| [MYOMO INC (MYO)](/companies/myo.md) | COM NEW | $3.8m | 1.4% | 3,637,886 |  | Reduced −209,386 |
| [OVID THERAPEUTICS INC (OVID)](/companies/ovid.md) | COM | $3.0m | 1.1% | 1,107,994 |  | Unchanged |
| [NEURAXIS INC (NRXS)](/companies/nrxs.md) | COM | $3.0m | 1.1% | 508,055 |  | Added +221,917 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $2.8m | 1.0% | 20,869 |  | New +20,869 |
| [INSPIREMD INC (NSPR)](/companies/nspr.md) | COM | $2.7m | 1.0% | 3,905,743 |  | Unchanged |
| REGENTIS BIOMATERIALS LTD | ORDINARY SHARES | $2.5m | 0.9% | 701,685 |  | Added +450,175 |
| SELLAS LIFE SCIENCES GROUP INC | PUT | $2.3m | 0.9% | 568,700 | Put | New +568,700 |
| POLYPID LTD | COM | $2.0m | 0.7% | 389,455 |  | Reduced −208,471 |
| [BIOFRONTERA INC (BFRI)](/companies/bfri.md) | COM NEW | $1.2m | 0.4% | 1,275,609 |  | Added +111,647 |
| [KURA ONCOLOGY INC (KURA)](/companies/kura.md) | COM | $1.1m | 0.4% | 100,000 |  | Unchanged |
| [SPRUCE BIOSCIENCES INC (SPRB)](/companies/sprb.md) | COM NEW | $1.1m | 0.4% | 20,000 |  | New +20,000 |
| [AQUESTIVE THERAPEUTICS INC (AQST)](/companies/aqst.md) | COM | $1.0m | 0.4% | 250,000 |  | Unchanged |
| [ONKURE THERAPEUTICS INC (OKUR)](/companies/okur.md) | COM CL A | $684.0k | 0.3% | 150,000 |  | Reduced −293,763 |
| [PEPGEN INC (PEPG)](/companies/pepg.md) | COM | $630.0k | 0.2% | 350,000 |  | New +350,000 |
| CG ONCOLOGY INC | CALL | $375.1k | 0.1% | 31,000 | Call | New +31,000 |
| EYEPOINT PHARMACEUTICALS INC | CALL | $130.8k | <0.1% | 50,300 | Call | New +50,300 |
| ISHARES TR | PUT | $110.0k | <0.1% | 500,000 | Put | New +500,000 |
| SPDR SERIES TRUST | PUT | $35.1k | <0.1% | 140,600 | Put | New +140,600 |
| TENAX THERAPEUTICS INC | PUT | $13.9k | <0.1% | 6,200 | Put | New +6,200 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ANNEXON INC (ANNX)](/companies/annx.md) | COM | $0 | 0.0% | 0 |  | Sold out −200,000 |
| ARRIVENT BIOPHARMA INC | CALL | $0 | 0.0% | 0 | Call | Sold out −108,900 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −75,000 |
| [CG ONCOLOGY INC (CGON)](/companies/cgon.md) | COM | $0 | 0.0% | 0 |  | Sold out −100,000 |
| [DEFINIUM THERAPEUTICS INC (DFTX)](/companies/dftx.md) | COM SHS | $0 | 0.0% | 0 |  | Sold out −125,000 |
| INVESCO QQQ TR | PUT | $0 | 0.0% | 0 | Put | Sold out −250,000 |
| [LIPOCINE INC (LPCN)](/companies/lpcn.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −221,616 |
| REPLIMUNE GROUP INC | CALL | $0 | 0.0% | 0 | Call | Sold out −1,275,600 |
| SPDR S&P 500 ETF TR | PUT | $0 | 0.0% | 0 | Put | Sold out −125,000 |
| UNIQURE NV | CALL | $0 | 0.0% | 0 | Call | Sold out −295,800 |
| VIRIDIAN THERAPEUTICS INC | PUT | $0 | 0.0% | 0 | Put | Sold out −263,600 |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $0 | 0.0% | 0 |  | Sold out −250,401 |

Source: SEC EDGAR, Form 13F-HR, accession 0001622627-26-000022. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.